These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6515028)

  • 1. [In vivo study of cellular immunity in patients with scleroderma].
    Olszewska Z; Arkuszewska C; Płuzańska A
    Przegl Dermatol; 1984; 71(4):317-25. PubMed ID: 6515028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

  • 3. [The immune status of scleroderma patients undergoing electroacupuncture].
    Glavinskaia TA; Rezaĭkina AV; Smirnova AV
    Vestn Dermatol Venerol; 1989; (4):44-7. PubMed ID: 2788340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immune response to collagen I in patients with systemic scleroderma].
    Vladimirtsev VA; Avdeeva ZhI; Guseva NG; Rassokhina II; Anan'eva LP
    Vopr Revm; 1982; (1):33-8. PubMed ID: 6178214
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
    Fleischmajer R; Perlish JS; West WP
    Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Types of anticellular structure antisera in scleroderma patients].
    Ni ZM
    Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):270-2, 318. PubMed ID: 8221243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating immune complexes in progressive systemic scleroderma and morphea].
    Yotsumoto H; Shimokawa Y; Hisadome H; Tashiro M
    Nihon Hifuka Gakkai Zasshi; 1983 May; 93(6):579-83. PubMed ID: 6620628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune deficiency states in autoimmune diseases].
    Niwa Y; Kano T
    Saishin Igaku; 1971 Mar; 26(3):591-607. PubMed ID: 4100713
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative evaluation of T-, B- and 0-lymphocyte populations in focal scleroderma].
    Fedorova EG
    Vestn Dermatol Venerol; 1980 Jun; (6):17-9. PubMed ID: 6967244
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-immunological parallels in patients with focal scleroderma].
    Suchkova TN; Kurmanova LV; Ermolin GA; Suchkov SV
    Vestn Dermatol Venerol; 1989; (2):13-9. PubMed ID: 2786297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
    Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic scleroderma: a clinical and immunological study.
    Jiang SJ; Chen SL; Su LD; Yu M; Ma GP; Wang WN; Xu JB; Huang DJ; Qian YY; Gui JS
    Chin Med J (Engl); 1986 Nov; 99(11):885-92. PubMed ID: 3107926
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma].
    Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF
    Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
    Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
    J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic findings in scleroderma in childhood].
    Stögmann W
    Monatsschr Kinderheilkd (1902); 1979 May; 127(5):308-10. PubMed ID: 460236
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological disorders and cytokine profile in systemic and localized sclerosis].
    Ter Arkh; 2012; 84(5):28-31. PubMed ID: 22830208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immunity in systemic scleroderma (author's transl)].
    Hattori A
    Nihon Hifuka Gakkai Zasshi; 1978 Apr; 88(5):347-58. PubMed ID: 149207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.